lobbying_activities: 1594200

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1594200	9b9d12fb-f0e3-45e7-a247-78ea5aa3e383	Q3	BROWN RUDNICK LLP	287895	HOSPIRA, INC.	2014	third_quarter	PHA	Issues relating to drug shortages; Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94).	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2014-10-17T15:14:34.880000-04:00